Global transcriptional response to interferon is a determinant of HCV treatment outcome and is modified by race. - Wikidata - wikimedia - TriplyDB

Global transcriptional response to interferon is a determinant of HCV treatment outcome and is modified by race.

Global transcriptional response to interferon is a determinant of HCV treatment outcome and is modified by race.

http://www.wikidata.org/entity/Q43001565

about

A diverse range of gene products are effectors of the type I interferon antiviral response Natural killer cells in hepatitis C: Current progress Defective Hepatic Response to Interferon and Activation of Suppressor of Cytokine Signaling 3 in Chronic Hepatitis C Lack of response to exogenous interferon-α in the liver of chimpanzees chronically infected with hepatitis C virus Peginterferon Pharmacokinetics in African American and Caucasian American Patients With Hepatitis C Virus Genotype 1 Infection The Evolution of the Major Hepatitis C Genotypes Correlates with Clinical Response to Interferon Therapy Human leukocyte antigen class II associations with hepatitis C virus clearance and virus‐specific CD4 T cell response among Caucasians and African Americans Pegylated interferon plus ribavirin for genotype Ib chronic hepatitis C in Japan Genomic scale analysis of racial impact on response to IFN-alpha Emerging concepts in biomarker discovery; the US-Japan Workshop on Immunological Molecular Markers in Oncology Down-regulation of the interferon signaling pathway in T lymphocytes from patients with metastatic melanoma.Oral activated charcoal prevents experimental cerebral malaria in mice and in a randomized controlled clinical trial in man did not interfere with the pharmacokinetics of parenteral artesunate.Cell subset prediction for blood genomic studies In vitro blood cell responsiveness to IFN-α predicts clinical response independently of IL28B in hepatitis C virus genotype 1 infected patients.Interferon-λ in HCV Infection and Therapy.Differential transcriptional responses to interferon-alpha and interferon-gamma in primary human hepatocytes.The induction of type I interferon production in hepatitis C-infected patients.Serum antibodies against CD28-- a new potential marker of dismal prognosis in melanoma patients Expression of Biliverdin Reductase A in peripheral blood leukocytes is associated with treatment response in HCV-infected patients Quantitation of pretreatment serum interferon-γ-inducible protein-10 improves the predictive value of an IL28B gene polymorphism for hepatitis C treatment response Gene expression profiling in acute allograft rejection: challenging the immunologic constant of rejection hypothesis.Gene-expression variation within and among human populations.Changes in gene expression during pegylated interferon and ribavirin therapy of chronic hepatitis C virus distinguish responders from nonresponders to antiviral therapy.Pathogenesis of chronic viral hepatitis: differential roles of T cells and NK cells Experimental Neuromyelitis Optica Induces a Type I Interferon Signature in the Spinal Cord.Early changes in interferon signaling define natural killer cell response and refractoriness to interferon-based therapy of hepatitis C patients.New take on comparative immunology: relevance to immunotherapy.Gene-expression profiling in vaccine therapy and immunotherapy for cancer Bottom up: a modular view of immunology.Cooperativity of adaptive and innate immunity: implications for cancer therapy.Single-cell, phosphoepitope-specific analysis demonstrates cell type- and pathway-specific dysregulation of Jak/STAT and MAPK signaling associated with in vivo human immunodeficiency virus type 1 infection.Plasma interferon-gamma-inducible protein-10 (IP-10) levels during acute hepatitis C virus infection.A genetic screen identifies interferon-α effector genes required to suppress hepatitis C virus replication Novel protease and polymerase inhibitors for the treatment of hepatitis C virus infection.Impaired interferon signaling is a common immune defect in human cancer.An overview about hepatitis C: a devastating virus.Interferon-lambda in the immune response to hepatitis B virus and hepatitis C virus.The interferon signaling pathway genes as biomarkers of hepatitis C virus disease progression and response to treatment.Type I and type II interferon responses in two human liver cell lines (Huh-7 and HuH6).Positive feedback regulation of type I IFN production by the IFN-inducible DNA sensor cGAS

P2860

Q24626018-9BF306D6-14E0-40B4-B1FC-646F39EAB8F9 Q26773264-EBC07D6D-54B7-45D6-A787-8163E2BB15DB Q27478298-448CEB88-5133-4D59-8D10-6062053FC96C Q27486088-C241ADE9-8ED4-4434-A9B5-3FEF8FD591A7 Q27488869-5F06F370-7CF0-43FA-BFCC-87809F374D68 Q27489040-597FECB9-1C66-4886-A7BC-F905800263F3 Q27489728-70096674-6CBC-46AF-976D-66D3E4B8E1A6 Q27490399-7E41770E-CE3B-4178-BD9F-13888B8D9F9D Q27490906-37455D5C-7A1F-4403-AFB8-0C5F6EE34B10 Q30438965-6EB81FAF-29DC-438E-A0A8-828BF6C30D2B Q33284046-BF1E90B2-C96B-42EB-B071-41884A61759C Q33564441-9EC8408B-EF38-4870-B81B-13A0E6AA1851 Q33942400-151B6B26-E3AD-400D-9F93-70E6CBD0E600 Q33958609-8B8045F6-F4CD-43A4-B312-6BAB00128E24 Q34047500-60D819E7-EF22-41BD-A27A-F31CD2BEF6ED Q34163327-4A722BCC-B5B9-435A-B041-238A648BF15B Q34208032-B9C1C82E-B334-45A6-871F-4AA4EA388255 Q34618599-86358BB2-1BD5-4EB8-8E48-E9D7E52DC48C Q34638990-F1490E7C-E742-4A2F-AB39-2E65D2EC36D8 Q34867045-16E9251A-8A15-4F1A-962E-5D85C6270FF7 Q35541507-801ABAB6-78F7-4773-9035-76C2F307C3A1 Q35677775-3A694FB7-3149-4618-BA2A-94952FC43F55 Q35785037-D12D9B91-FBA9-4272-A1EE-B8EEDA9238B7 Q35786326-7B7A2C04-9932-44DC-852B-A34A0404F6DB Q35962565-FF8A4339-D179-4382-8EE4-D128BFB094D3 Q35964140-4FDC7E9F-967B-4E0A-8DFF-C6880A114E7D Q36126352-98E7AC6A-DCD2-4802-BF0F-A91B560711F7 Q36138329-EE8C71EF-650C-4C2F-95D3-68FCBC5A102A Q36158286-37BF746B-E85B-41EA-A284-2D9CDDB3787B Q36429508-DD448543-0A98-420A-BEC8-FDDB258F7333 Q36498220-0F709772-7AFD-47FD-BD39-650586A7DE77 Q36874661-01160CAC-59EA-4835-8641-A13D4C1DF808 Q36881106-0A272DFB-97AF-4A5D-9B21-D1427BA81469 Q36904844-7352E789-64CD-4FF8-990C-B263AA76481E Q37211332-90A9E55F-9FE7-4A4F-B48E-5BD1663013F8 Q37719516-E68382CA-4419-4A32-B208-FDB62FA9AA5F Q37774371-6C8F00AE-05FF-463D-BCD2-FD8EC628EE94 Q37997042-1992008D-D617-4D2F-9D41-7B242EDC2B23 Q38783715-197AC2AD-F3B9-400C-A52B-DBBD4A5F2628 Q38917687-7E94AA19-B93B-417E-BCC1-21A6AB1C9A37

P2860

Global transcriptional response to interferon is a determinant of HCV treatment outcome and is modified by race.

http://www.wikidata.org/entity/Q43001565

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh-hant

name

Global transcriptional respons ...... tcome and is modified by race.

@en

Global transcriptional respons ...... tcome and is modified by race.

@nl

type

label

Global transcriptional respons ...... tcome and is modified by race.

@en

Global transcriptional respons ...... tcome and is modified by race.

@nl

prefLabel

Global transcriptional respons ...... tcome and is modified by race.

@en

Global transcriptional respons ...... tcome and is modified by race.

@nl

P1433

Q43001565-1CC14D64-BDE7-401F-8355-302E6A0061C3

P1476

Q43001565-4355D561-91FB-4C23-9820-FDC7F6F5C4B0

P2093

Q43001565-1B660E2B-C279-42F2-8FC2-466A3483656C

Q43001565-53E09200-F57B-4529-9759-863137C690B3

Q43001565-5D32C5C9-5A86-4D36-ACA5-1C1F3E1CD72A

Q43001565-8F8C40FD-4C57-477E-9DA0-9B9758ED7B93

Q43001565-97E5A869-DAA3-46E9-8F63-391319136324

Q43001565-E54DBAF1-052F-4C27-8EDE-7532F42990E2

Q43001565-F777B53A-2C28-46D0-8DC2-0A8BEB207B2F

Q43001565-F8B50CE5-60BC-4ECA-9075-57175E7C1BCA

Q43001565-FD7C982D-9740-4EBD-A3F5-468FFDA4589C

P304

Q43001565-56C4D40F-4E11-47FB-A46D-CD5349065CF0

P31

Q43001565-6703BFC4-51E5-4292-A796-4A064553C45D

P356

Q43001565-70FDD28D-254F-4EE3-A87F-6655A6E20FB7

P407

Q43001565-5549038F-ADC4-46D7-BD0D-85057D086F86

P433

Q43001565-D04A236F-A517-43E2-A5ED-4DFFD00437C9

P478

Q43001565-D739432D-AB35-48B0-9325-FFE4A6A7656A

P50

Q43001565-2F053B2D-6C32-40DF-B368-CB02A8635A90

Q43001565-4E60CAA8-78D9-497E-A977-9EABF6E84B58

Q43001565-94E4328A-6CEC-4C7F-85B1-DC1805FD70B2

P577

Q43001565-254692CA-16CC-41CD-A295-4497EAEF7206

P698

Q43001565-1FBC3CB9-AE36-4931-B185-9B259A22EE5C

P356

P1433

P1476

Global transcriptional respons ...... tcome and is modified by race.

@en

P2093

Aijaz Ahmed

http://www.w3.org/2001/XMLSchema#string

Garry P Nolan

http://www.w3.org/2001/XMLSchema#string

Matthew B Hale

http://www.w3.org/2001/XMLSchema#string

Neil Risch

http://www.w3.org/2001/XMLSchema#string

Ramsey Cheung

http://www.w3.org/2001/XMLSchema#string

Teresa L Wright

http://www.w3.org/2001/XMLSchema#string

Xiao-Song He

http://www.w3.org/2001/XMLSchema#string

Xuhuai Ji

http://www.w3.org/2001/XMLSchema#string

Yaqian Guo

http://www.w3.org/2001/XMLSchema#string

P304

352-359

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HEP.21267

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

44

http://www.w3.org/2001/XMLSchema#string

P50

Robert Tibshirani

Harry B. Greenberg

Lawrence M Pfeffer

P577

2006-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16871572

http://www.w3.org/2001/XMLSchema#string